26 September 2023 - interim results
The AIM-quoted international; healthcare group has announced its interim results for the six months to 30 June and these have revealed modest growth in revenue (on a see-through basis) of 1% as this rose to £82.4m. However, underlying pre-tax profit fell by 48% to £10.3m with a change in the product mix leading to a reduction in gross margin whilst there was a significant increase in finance costs during the period. Underlying earnings per share fell to 1.58p (2022: 2.90p).but there was no interim dividend as the . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
